Browse drugs

…cating an additional mechanism of action for PK-E1 like that of pembrolizumab (Keytruda) and nivolumab (Opdivo).Conclusions As novel bispecif…

… mutational burden in predicting benefit. In KEAP1-mutant PDXs, WZB117 restored sensitivity to anti-PD-1 therapy, validating translati…

…ade (ICB) and hormonal therapy/RT, we tested the combination of atezolizumab (PD-L1 blockade) plus ARPI, ADT and RT to the prostate in men w…

… for safety and PD assessment.References Islam SA, et al. Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+…

…erapy treatment groups, whereas MM001i tumors responded only to αCTLA-4. Both tumor cell lines also triggered robust memory responses. …

…ypermutated profile (+190 genes), showing a durable response to pembrolizumab.Methods A 57-year-old male was diagnosed with moderately differ…

…D, Griffith M, Griffith OL, Adkins DR. Neoadjuvant and adjuvant pembrolizumab in resectable locally advanced, human papillomavirus-unrelated …

… hepatocellular carcinoma (HCC) exhibiting varying responses to Atezolizumab plus Bevacizumab (Atezo/Bev), and profiled the tumor ecosystems…

…analyzed across multiple timepoints to resolve kinetics.Results Nivolumab induced three distinct response kinetics across the CRC patient…

…er tumor necrosis induced by TATE could enhance the efficacy of pembrolizumab (pembro).Methods Subjects with mCRC-MSS who had progressed on 2…

…ior outcome for patients receiving anti-CD19 CAR-T cell therapy axicabtagene ciloleucel (axi-cel) versus historical standard of care. However, about 60…

…s provided informed consent.Results Upon ex-vivo treatment with forimtamig, T cells were capable of secreting cytokines and killing endoge…